Skip Ribbon Commands
Skip to main content
 


SPORE 24: Biomarkers and dysplastic respiratory epithelium (version B).


Trial Focus

Lung Cancer

Objective

         Not available at this time

IRB Protocol #

00-1108

Trial Status

OPEN

Principle Investigator

YORK MILLER

Sponsor

NCI

Contact

MARY JACKSON at (303)724-1650 or MARY.K.JACKSON@UCDENVER.EDU

Location

Dept Of Veterans Affairs Medical Center University of Colorado Hospital Dept Of Veterans Affairs Medical Center University of Colorado Hospital

Eligibility and Other Participant Information


What To Expect : Bronchoscopy, blood draw, urine collection, and sputum collection // Eligibility criteria : 1) Individuals identified through the SPORE Tissue Procurement Screening Project with moderate or severe dysplasia. 2) Patients identified by private and academis physicians with moderate or severe dysplasia on cytology. 3) One year or greater survisors of one or more aerodigestive system cancers. 4) Patients with head and neck cancers who are undergoing routine panendoscopy. 5)Patients undergoing resection of a bronchogenic cancer. 6) Fully resected Stage I non-small cell cancer patients. 7) Patient's undergoing bronchoscopy for diagnosis or staging of suspected lung cancer. 8) Subjects with previous high-grade dysplasia or worse undergoing subsequent bronchoscopy for serveillance or monitoring of response to endobronchial treatment. 9) Patients without dysplasia will be: normal paid volunteersEligibility criteria : 1) Individuals identified through the SPORE Tissue Procurement Screening Project with moderate or severe dysplasia. 2) Patients identified by private and academis physicians with moderate or severe dysplasia on cytology. 3) One year or greater survisors of one or more aerodigestive system cancers. 4) Patients with head and neck cancers who are undergoing routine panendoscopy. 5)Patients undergoing resection of a bronchogenic cancer. 6) Fully resected Stage I non-small cell cancer patients. 7) Patient's undergoing bronchoscopy for diagnosis or staging of suspected lung cancer. 8) Subjects with previous high-grade dysplasia or worse undergoing subsequent bronchoscopy for serveillance or monitoring of response to endobronchial treatment. 9) Patients without dysplasia will be: normal paid volunteers